Therapeutic Potential of Melaleuca alternifolia Essential Oil in New Drug Delivery Systems

Author(s): Karoll M. A. de Assis, Renaly I. de A. Rêgo, Demis F. de Melo, Laryssa M. da Silva, João A. Oshiro- Júnior, Fábio R. Formiga, Vinícius C. Pires, Ádley A. N. de Lima, Attilio Converti*, Bolívar P. G. de L. Damasceno

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 33 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Medicinal plants produce secondary metabolites with special biological activities, which may be used as new therapeutic alternatives. For instance, tea tree essential oil (TTO) was shown to exert antimicrobial, antifungal, anthelmintic, antiviral, anti-tumor and anti-inflammatory activities. Due to their thermal instability, active principles can be easily degraded by physicochemical processes; therefore, they must be protected to increase their time of action and improve their controlled release. The aim of this review is to discuss formulations incorporating encapsulated TTO as the active ingredient. Micro and nanoencapsulated systems proved to be more thermostable than TTO and to exert better antimicrobial, antifungal, antiparasitic and larvicidal effects. Nanoencapsulation also reduced oil toxicity. Emulsified and hybrid systems developed by various methods showed improved repellent, antibacterial, antifungal and anti-inflammatory activities, thereby proving promising for the pharmaceutical industry. Liposomal formulations produced by hydration of lipid films exhibited constant rate of terpinen-4-ol release. In addition, their incorporation into biomaterials, such as sponges, nanofibers and films, showed great potential for treating infections. Mainly due to the advantages of their incorporation into new drug delivery systems over conventional formulations, there is an interest in the development of systems containing TTO as a pharmaceutical ingredient of plant origin.

Keywords: Emulsified Systems, Nanoparticulate systems, Pharmacological effects, Polymeric systems, Tea Tree, secondary metabolites.

[1]
Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep 2017; 50(3): 111-6.
[http://dx.doi.org/10.5483/BMBRep.2017.50.3.221] [PMID: 27998396]
[2]
Shen B. A new golden age of natural products drug discovery. Cell 2015; 163(6): 1297-300.
[http://dx.doi.org/10.1016/j.cell.2015.11.031] [PMID: 26638061]
[3]
Lanas A, Chan FKL. Peptic ulcer disease. Lancet 2017; 390(10094): 613-24.
[http://dx.doi.org/10.1016/S0140-6736(16)32404-7] [PMID: 28242110]
[4]
Sá RCS, Andrade LN, Oliveira RRB, de Sousa DP. A review on anti-inflammatory activity of phenylpropanoids found in essential oils. Molecules 2014; 19(2): 1459-80.
[http://dx.doi.org/10.3390/molecules19021459] [PMID: 24473208]
[5]
Guo Z. The modification of natural products for medical use. Acta Pharm Sin B 2017; 7(2): 119-36.
[http://dx.doi.org/10.1016/j.apsb.2016.06.003] [PMID: 28303218]
[6]
Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 2015; 14(2): 111-29.
[http://dx.doi.org/10.1038/nrd4510] [PMID: 25614221]
[7]
Dutra RC, Campos MM, Santos ARS, Calixto JB. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives. Pharmacol Res 2016; 112: 4-29.
[http://dx.doi.org/10.1016/j.phrs.2016.01.021] [PMID: 26812486]
[8]
Flores FC, Beck RCR, da Silva C de B. Essential oils for treatment for onychomycosis: A mini-review. Mycopathologia 2016; 181(1-2): 9-15.
[http://dx.doi.org/10.1007/s11046-015-9957-3] [PMID: 26481920]
[9]
Carneiro FM, da Silva MJP, Borges LL, Albernaz LC, Costa JDP. Tendências dos estudos com plantas medicinais no Brasil. Rev Sapiência Soc Saberes e Práticas Educ 2014; 3(2): 44-75.
[10]
Françoso RD, Haidar RF, Machado RB. Tree species of South America central savanna: Endemism, marginal areas and the relationship with other biomes. Acta Bot Bras 2016; 30(1): 78-86.
[http://dx.doi.org/10.1590/0102-33062015abb0244]
[11]
Frauches N, Amaral T, Largueza C, Teodoro A. Brazilian myrtaceae fruits: A review of anticancer proprieties. Br J Pharm Res 2016; 12(1): 1-15.
[http://dx.doi.org/10.9734/BJPR/2016/26782]
[12]
Mertas A, Garbusińska A, Szliszka E, Jureczko A, Kowalska M, Król W. The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. Biomed Res Int 2015; 2015590470
[http://dx.doi.org/10.1155/2015/590470] [PMID: 25722982]
[13]
Ebani VV, Najar B, Bertelloni F, Pistelli L, Mancianti F, Nardoni S. Chemical composition and in vitro antimicrobial efficacy of sixteen essential oils against Escherichia coli and Aspergillus fumigatus isolated from poultry. Vet Sci 2018; 5(3): 1-13.
[http://dx.doi.org/10.3390/vetsci5030062] [PMID: 29941827]
[14]
Sharifi-Rad J, Salehi B, Varoni EM, et al. Plants of the Melaleuca genus as antimicrobial agents: From farm to pharmacy. Phytother Res 2017; 31(10): 1475-94.
[http://dx.doi.org/10.1002/ptr.5880] [PMID: 28782167]
[15]
Santos RCV, Lopes LQS, Alves CF dos S, et al. Antimicrobial activity of tea tree oil nanoparticles against American and European foulbrood diseases agents. J Asia Pac Entomol 2014; 17(3): 343-7.
[http://dx.doi.org/10.1016/j.aspen.2014.02.003]
[16]
Ebling De Souza M, Quintana Soares Lopes L, De Almeida Vaucher R, et al. Antimycobacterial and antifungal activities of Melaleuca alternifolia oil nanoparticles. J Drug Deliv Sci Technol 2014; 24(5): 559-60.
[http://dx.doi.org/10.1016/S1773-2247(14)50105-0]
[17]
Grando TH, Baldissera MD, Gressler LT, et al. Melaleuca alternifolia anthelmintic activity in gerbils experimentally infected by Haemonchus contortus. Exp Parasitol 2016; 170: 177-83.
[http://dx.doi.org/10.1016/j.exppara.2016.09.004] [PMID: 27646626]
[18]
Pazinatto Boito J, Santos RC, Vaucher RA, et al. Evaluation of tea tree oil for controlling Rhipicephalus microplus in dairy cows. Vet Parasitol 2016; 225: 70-2.
[http://dx.doi.org/10.1016/j.vetpar.2016.05.031] [PMID: 27369577]
[19]
Volpato A, Lorenzetti WR, Zortea T, Giombelli LCDD, Baretta D, Santos RCV, et al. Melaleuca alternifolia essential oil against the lesser mealworm (Alphitobius diaperinus) and its possible effect on the soil fauna. Rev Bras Cienc Avic 2016; 18(1): 41-6.
[http://dx.doi.org/10.1590/1516-635X1801041-046]
[20]
Ramadan MA, Shawkey AE, Rabeh MA, Abdellatif AO. Promising antimicrobial activities of oil and silver nanoparticles obtained from Melaleuca alternifolia leaves against selected skin-infecting pathogens. J Herb Med 2019; (June): 100289
[http://dx.doi.org/10.1016/j.hermed.2019.100289]
[21]
Pazyar N, Yaghoobi R, Rafiee E, Mehrabian A, Feily A. Skin wound healing and phytomedicine: a review. Skin Pharmacol Physiol 2014; 27(6): 303-10.
[http://dx.doi.org/10.1159/000357477] [PMID: 24993834]
[22]
Souza CF, Baldissera MD, Silva L de L, Geihs MA, Baldisserotto B. Is monoterpene terpinen-4-ol the compound responsible for the anesthetic and antioxidant activity of Melaleuca alternifolia essential oil (tea tree oil) in silver catfish? Aquaculture 2018; 486: 217-23.
[http://dx.doi.org/10.1016/j.aquaculture.2017.12.025]
[23]
de Freitas Souza C, Baldissera MD, Descovi S, et al. Melaleuca alternifolia essential oil abrogates hepatic oxidative damage in silver catfish (Rhamdia quelen) fed with an aflatoxin-contaminated diet. Comp Biochem Physiol Part - C Toxicol Pharmacol 2019; 221: 10-20.
[http://dx.doi.org/10.1016/j.cbpc.2019.03.007]
[24]
Low P, Clark AM, Chou TC, Chang TC, Reynolds M, Ralph SJ. Immunomodulatory activity of Melaleuca alternifolia concentrate (MAC): inhibition of LPS-induced NF-κB activation and cytokine production in myeloid cell lines. Int Immunopharmacol 2015; 26(1): 257-64.
[http://dx.doi.org/10.1016/j.intimp.2015.03.034] [PMID: 25858876]
[25]
Karamanoli K, Ainalidou A, Bouzoukla F, Vokou D. Decomposition profiles of leaf essential oils in the soil environment. Ind Crops Prod 2018; 124: 397-401.
[http://dx.doi.org/10.1016/j.indcrop.2018.07.082]
[26]
El Asbahani A, Miladi K, Badri W, et al. Essential oils: from extraction to encapsulation. Int J Pharm 2015; 483(1-2): 220-43.
[http://dx.doi.org/10.1016/j.ijpharm.2014.12.069] [PMID: 25683145]
[27]
Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B 2015; 5(5): 442-53.
[http://dx.doi.org/10.1016/j.apsb.2015.07.003] [PMID: 26579474]
[28]
Volić M, Pajić-Lijaković I, Djordjević V, et al. Alginate/soy protein system for essential oil encapsulation with intestinal delivery. Carbohydr Polym 2018; 200: 15-24.
[http://dx.doi.org/10.1016/j.carbpol.2018.07.033]] [PMID: 30177152]
[29]
Chen M, Hu Y, Zhou J, et al. Facile fabrication of tea tree oil-loaded antibacterial microcapsules by complex coacervation of sodium alginate/quaternary ammonium salt of chitosan. RSC Advances 2016; 6(16): 13032-9.
[http://dx.doi.org/10.1039/C5RA26052C]
[30]
Sagave L, Gressler LT, Flores FC, et al. Atividade de nanoformulações de Melaleuca alternifolia e terpinen-4-ol em isolados de Rhodococcus equi. Arq Bras Med Vet Zootec 2015; 67(1): 221-6.
[http://dx.doi.org/10.1590/1678-7454]
[31]
de Souza ME, Clerici DJ, Verdi CM, et al. Antimicrobial activity of Melaleuca alternifolia nanoparticles in polymicrobial biofilm in situ. Microb Pathog 2017; 113: 432-7.
[http://dx.doi.org/10.1016/j.micpath.2017.11.005] [PMID: 29162482]
[32]
Comin VM, Lopes LQS, Quatrin PM, et al. Influence of Melaleuca alternifolia oil nanoparticles on aspects of Pseudomonas aeruginosa biofilm. Microb Pathog 2016; 93: 120-5.
[http://dx.doi.org/10.1016/j.micpath.2016.01.019] [PMID: 26821356]
[33]
Souza CF, Baldissera MD, Santos RCV, Raffin RP, Baldisserotto B. Nanotechnology improves the therapeutic efficacy of Melaleuca alternifolia essential oil in experimentally infected Rhamdia quelen with Pseudomonas aeruginosa. Aquaculture 2017; 473: 169-71.
[http://dx.doi.org/10.1016/j.aquaculture.2017.02.014]
[34]
Baldissera MD, Souza CF, Doleski PH, Santos RCV, Raffin RP, Baldisserotto B. Involvement of xanthine oxidase inhibition with the antioxidant property of nanoencapsulated Melaleuca alternifolia essential oil in fish experimentally infected with Pseudomonas aeruginosa. J Fish Dis 2018; 41(5): 791-6.
[http://dx.doi.org/10.1111/jfd.12779] [PMID: 29350421]
[35]
Souza ME, Lopes LQS, Bonez PC, et al. Melaleuca alternifolia nanoparticles against Candida species biofilms. Microb Pathog 2017; 104: 125-32.
[http://dx.doi.org/10.1016/j.micpath.2017.01.023] [PMID: 28089949]
[36]
Madalosso RG, Verdi CM, Souza ME, et al. In vitro and in vivo effects of Melaleuca alternifolia nanoparticles in Meloidogyne sp. J Asia Pac Entomol 2017; 20(4): 1344-9.
[http://dx.doi.org/10.1016/j.aspen.2017.10.002]
[37]
Yim WT, Bhandari B, Jackson L, James P. Repellent effects of Melaleuca alternifolia (tea tree) oil against cattle tick larvae (Rhipicephalus australis) when formulated as emulsions and in β-cyclodextrin inclusion complexes. Vet Parasitol 2016; 225: 99-103.
[http://dx.doi.org/10.1016/j.vetpar.2016.06.007] [PMID: 27369582]
[38]
de Souza Silveira Valente J, de Oliveira da Silva Fonseca A, Brasil CL, et al. In vitro activity of Melaleuca alternifolia (tea tree) in its free oil and nanoemulsion formulations against Pythium insidiosum. Mycopathologia 2016; 181(11-12): 865-9.
[http://dx.doi.org/10.1007/s11046-016-0051-2] [PMID: 27544535]
[39]
Li M, Zhu L, Liu B, et al. Tea tree oil nanoemulsions for inhalation therapies of bacterial and fungal pneumonia. Colloids Surf B Biointerfaces 2016; 141: 408-16.
[http://dx.doi.org/10.1016/j.colsurfb.2016.02.017] [PMID: 26895502]
[40]
Low WL, Kenward MAK, Amin MCIM, Martin C. Ionically crosslinked chitosan hydrogels for the controlled release of antimicrobial essential oils and metal ions for wound management applications. Medicines (Basel) 2016; 3(1): 8.
[http://dx.doi.org/10.3390/medicines3010008] [PMID: 28930118]
[41]
Flores FC, De Lima JA, Da Silva CR, et al. Hydrogels containing nanocapsules and nanoemulsions of tea tree oil provide antiedematogenic effect and improved skin wound healing. J Nanosci Nanotechnol 2015; 15(1): 800-9.
[http://dx.doi.org/10.1166/jnn.2015.9176] [PMID: 26328444]
[42]
Catanzano O, Straccia MC, Miro A, et al. Spray-by-spray in situ cross-linking alginate hydrogels delivering a tea tree oil microemulsion. Eur J Pharm Sci 2015; 66: 20-8.
[http://dx.doi.org/10.1016/j.ejps.2014.09.018] [PMID: 25277680]
[43]
Ge Y, Ge M. Distribution of Melaleuca alternifolia essential oil in liposomes with Tween 80 addition and enhancement of in vitro antimicrobial effect. J Exp Nanosci 2016; 11(5): 345-58.
[http://dx.doi.org/10.1080/17458080.2015.1065013]
[44]
Ge Y, Tang J. Fabrication, characterization and antimicrobial property of natural TTOLs/CS composite sponges. Fibers Polym 2016; 17(6): 862-72.
[http://dx.doi.org/10.1007/s12221-016-6232-2]
[45]
Ge Y, Tang J, Fu H, Fu Y, Wu Y. Characteristics, Controlled-release and antimicrobial properties of tea tree oil liposomes-incorporated chitosan-based electrospun nanofiber mats. Fibers Polym 2019; 20(4): 698-708.
[http://dx.doi.org/10.1007/s12221-019-1092-1]
[46]
Zhang W, Huang C, Kusmartseva O, Thomas NL, Mele E. Electrospinning of polylactic acid fibres containing tea tree and manuka oil. React Funct Polym 2017; 117(June): 106-11.
[http://dx.doi.org/10.1016/j.reactfunctpolym.2017.06.013]
[47]
Bagchi B, Banerjee S, Kool A, et al. Synthesis of eucalyptus/tea tree oil absorbed biphasic calcium phosphate-PVDF polymer nanocomposite films: a surface active antimicrobial system for biomedical application. Phys Chem Chem Phys 2016; 18(25): 16775-85.
[http://dx.doi.org/10.1039/C6CP03493D] [PMID: 27271864]
[48]
Li M, Zhu L, Zhang T, Liu B, Du L, Jin Y. Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia. J Pharm Pharmacol 2017; 69(11): 1458-67.
[http://dx.doi.org/10.1111/jphp.12788] [PMID: 28809447]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 33
Year: 2020
Published on: 23 September, 2020
Page: [4048 - 4055]
Pages: 8
DOI: 10.2174/1381612826666200305124041
Price: $65

Article Metrics

PDF: 23
HTML: 3
EPUB: 1
PRC: 1